Browse the corpus

Electrocochleography (ECochG) stands at the forefront of diagnostic audiology, offering a unique window into the electrical activity of the inner ear. This 30-minute test involves electrode placement on the scalp and within the ear canal or through the tympanic membrane, capturing the cochlear microphonic (CM), action potential (AP), summation potential (SP), and auditory nerve neurophonic (ANN). In this activity, participants will delve into the pivotal role of the interprofessional team in evaluating and treating patients undergoing ECochG, exploring its safety, reliability, and applications in diagnosing a spectrum of hearing disorders, including Ménière's disease and auditory neuropathy. Recent advancements in ECochG technology are scrutinized, particularly its role in real-time feedback during cochlear implantation surgeries. Participants will gain a comprehensive understanding of the intricacies of ECochG, examining the interpretation of APs with a focus on N1 and N2 peaks and the clinical significance of the SP:AP amplitude ratio in the diagnosis of Ménière disease and endolymphatic hydrops. The activity will also shed light on the ANN, its frequency variations with stimulus frequency, and its role as a reliable indicator of auditory neuropathy. This activity empowers healthcare professionals with the knowledge to effectively integrate ECochG into clinical practice and enhance patient outcomes in auditory diagnostics and intervention. Objectives: Apply the fundamental principles of electrocochleography to identify the electrical potentials in the inner ear. Differentiate between normal and pathological waveforms in electrocochleography to make appropriate diagnostic decisions. Evaluate the impact of probe placement and individual patient anatomy on electrocochleography results to ensure consistency in data interpretation. Create strategies with all interprofessional team members, including specialists such as otolaryngologists, electrophysiologists, audiologists, and speech and language pathologists, to provide efficient, comprehensive, and coordinated care. Access free multiple choice questions on this topic.

Electrocochleography (ECochG) is a testing procedure that enables the clinician to assess cochlear electrical potentials. While it can be challenging to perform and has been largely replaced by more convenient tests, it continues to be used in several clinical scenarios for diagnostic and intraoperative purposes. In recent years, advances in technology and a greater understanding of cochlear physiology have further enhanced the utility of ECochG, particularly in monitoring the functional status of the cochlea during cochlear implantation surgeries. ECochG comprises 3 potentials: the cochlear microphonic (CM), the action potential (AP), and the summation potential (SP) (see Image. Electrocochleography Diaphragm).[1] The CM is an alternating current resembling the waveform of the stimulus. It is primarily generated by the outer hair cells. The quality of the CM recording is highly variable and may be easily confused with stimulus artifacts.[1] Production of an artifact is much less likely when the stimulation source is intracochlear (ie, via a cochlear implant), and the CM may demonstrate post-implantation changes after insertion. Furthermore, the real-time feedback offered by ECochG during cochlear implantation has been used to ensure optimal placement of the implant electrodes, minimize trauma to the cochlear structures, and preserve residual hearing. Action potentials represent the compound (ie, summed) response of clusters of nerve fibers firing in response to the frequency of a given stimulus. The AP initiates at the onset of the stimulus and is mainly produced by the nerve fibers in the basal turn of the cochlea that respond to high-frequency sounds, especially in response to transient stimuli.[2] APs are generally interpreted using 2 negative peaks, N1 and N2, which correlate to auditory brainstem response (ABR) waves I and II.[1][3][4] The salient features of N1 and N2 are their magnitude and latency, with magnitude referring to the number and intensity of nerve fibers firing. In contrast, latency is the time that elapses between the stimulus and the appearance of the N1 peak, similar to absolute latency in ABR recordings.

Action potentials represent the compound (ie, summed) response of clusters of nerve fibers firing in response to the frequency of a given stimulus. The AP initiates at the onset of the stimulus and is mainly produced by the nerve fibers in the basal turn of the cochlea that respond to high-frequency sounds, especially in response to transient stimuli.[2] APs are generally interpreted using 2 negative peaks, N1 and N2, which correlate to auditory brainstem response (ABR) waves I and II.[1][3][4] The salient features of N1 and N2 are their magnitude and latency, with magnitude referring to the number and intensity of nerve fibers firing. In contrast, latency is the time that elapses between the stimulus and the appearance of the N1 peak, similar to absolute latency in ABR recordings. The SP is a direct current potential resulting from signal transduction initiated by the vibration of the basilar membrane. The SP is clinically most important concerning the AP, as the SP:AP amplitude ratio is often used to diagnose patients with Ménière disease (MD) or endolymphatic hydrops (ELH).[1] The auditory nerve also produces a potential called the auditory nerve neurophonic (ANN). Its frequency varies with stimulus frequency due to phase-locking, particularly with lower-frequency stimuli. When the ANN is decreased or absent, it strongly indicates auditory neuropathy.

As TT ECochG may be uncomfortable and poorly tolerated for patients in the awake setting, it typically requires sedation or anesthesia. Thus, the inherent risks of sedation or anesthesia should be discussed with patients if this method is employed instead of ET ECochG. Of primary concern with TT ECochG is accidental puncturing of the round window, which may result in perilymph leakage into the middle ear and create a potential for hearing loss. ET ECochG is very well tolerated, with no commonly reported complications.[18]